Francesco ATZORI | Attending Phisician | Doctor of Medicine | Università degli studi di Cagliari, Cagliari | UNICA | Azienda Ospedaliero-Universitaria di Cagliari
Daniel CASTELLANO | Hospital Universitario 12 de Octubre, Madrid | 12OCTUBRE | Medical Oncology Department
Alessandro RIZZO | Medical Doctor | Ospedale Oncologico "Giovanni Paolo II" di Bari, Bari | IRCCS Bari | Department of Medical Oncology
SCIENTIFIC REPORT 2010 - 2011 - IOV
Carcinoma renale a ESMO 2021, uno sguardo d'insieme - OncoInfo
JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study | HTML
Camillo Porta - Medical Doctor - Università degli Studi di Bari | LinkedIn
Loop | Camillo Porta
Tweets with replies by Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter
Prof. Camillo Porta – Epidemiologia del Carcinoma Renale a Cellule Chiare - YouTube
Alessandra Bearz's research works | CRO Centro di Riferimento Oncologico di Aviano, Aviano (CRO) and other places
Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter
Nicola SILVESTRIS | Full professor | Professor | Università degli Studi di Messina, Messina | UNIME - Page 4
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting | Future Oncology
Intervista Prof. Camillo Porta - YouTube
Sebastiano BUTI | Medical Doctor | MD, PhD | University Hospital of Parma, Parma | AOUP | Reparto di Oncologia medica - Page 8
Università di Bari, al via la «rivoluzione» dell'oncologia al Policlinico - La Gazzetta del Mezzogiorno
Loop | Camillo Porta
thumbnail
Giampietro GASPARINI | Managing Director | Oncology
Le nuove terapie contro il tumore al rene - YouTube
Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey | PLOS ONE
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting | Future Oncology
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme - De Giorgi - 2019 - BJU International - Wiley Online Library
